HC Wainwright & Co. Maintains Buy on Jade Biosciences, Raises Price Target to $35

HC Wainwright & Co. analyst Arthur He maintains Jade Biosciences (NASDAQ:JBIO) with a Buy and raises the price target from $25 to $35.